-
1
-
-
0027253654
-
Autoxidation kinetics of aqueous nitric oxide
-
Ford PC, Wink DA, Stanbury DM. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett 1993; 326: 1-3.
-
(1993)
FEBS Lett
, vol.326
, pp. 1-3
-
-
Ford, P.C.1
Wink, D.A.2
Stanbury, D.M.3
-
2
-
-
0031425115
-
A tutorial on the diffusibility and reactivity of free nitric oxide
-
Lancaster Jr. JR. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997; 1: 18-30.
-
(1997)
Nitric Oxide
, vol.1
, pp. 18-30
-
-
Lancaster Jr., J.R.1
-
3
-
-
0023505509
-
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
-
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 9265-9269
-
-
Ignarro, L.J.1
Buga, G.M.2
Wood, K.S.3
Byrns, R.E.4
Chaudhuri, G.5
-
4
-
-
0024296032
-
Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain
-
Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-8.
-
(1988)
Nature
, vol.336
, pp. 385-388
-
-
Garthwaite, J.1
Charles, S.L.2
Chess-Williams, R.3
-
5
-
-
0024208276
-
Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate
-
Marletta, MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
-
(1988)
Biochemistry
, vol.27
, pp. 8706-8711
-
-
Marletta, M.A.1
Yoon, P.S.2
Iyengar, R.3
Leaf, C.D.4
Wishnok, J.S.5
-
6
-
-
0025883342
-
Nitric oxide: Physiology, pathophysiology, and pharmacology
-
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
-
(1991)
Pharmacol Rev
, vol.43
, pp. 109-142
-
-
Moncada, S.1
Palmer, R.M.2
Higgs, E.A.3
-
7
-
-
68149169007
-
What is the real physiological NO concentration in vivo?
-
Hall CN, Garthwaite J. What is the real physiological NO concentration in vivo? Nitric Oxide 2009; 21(2): 92-103.
-
(2009)
Nitric Oxide
, vol.21
, Issue.2
, pp. 92-103
-
-
Hall, C.N.1
Garthwaite, J.2
-
8
-
-
30444456489
-
Nitric oxide and metastatic cell behaviour
-
Williams EL, Djamgoz MBA. Nitric oxide and metastatic cell behaviour. BioEssays 2005; 27: 1228-38.
-
(2005)
BioEssays
, vol.27
, pp. 1228-1238
-
-
Williams, E.L.1
Djamgoz, M.B.A.2
-
12
-
-
77949464599
-
-
Hickok JR, Thomas. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Design 2010; 16(4): 381-391.
-
Hickok JR, Thomas. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Design 2010; 16(4): 381-391.
-
-
-
-
13
-
-
77949442081
-
-
Ma Q, Wang Z, Zhang M, Hu H, Li J, Zhang D, et al. Targeting the L-arginine-Nitric Oxide pathway for cancer treatment. Curr Pharm Design 2010; 16(4): 392-410.
-
Ma Q, Wang Z, Zhang M, Hu H, Li J, Zhang D, et al. Targeting the L-arginine-Nitric Oxide pathway for cancer treatment. Curr Pharm Design 2010; 16(4): 392-410.
-
-
-
-
14
-
-
77949463994
-
-
Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr Pharm Design 2010; 16(4): 411-420.
-
Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr Pharm Design 2010; 16(4): 411-420.
-
-
-
-
15
-
-
77949461469
-
-
Wang L, Xie K. Nitric oxide and pancreatic cancer pathogenesis, prevention and treatment. Curr Pharm Design 2010; 16(4): 421-427.
-
Wang L, Xie K. Nitric oxide and pancreatic cancer pathogenesis, prevention and treatment. Curr Pharm Design 2010; 16(4): 421-427.
-
-
-
-
16
-
-
77949460820
-
-
Badn W, Siesjö P. The dual role of nitric oxide in glioma. Curr Pharm Design 2010; 16(4): 428-430.
-
Badn W, Siesjö P. The dual role of nitric oxide in glioma. Curr Pharm Design 2010; 16(4): 428-430.
-
-
-
-
17
-
-
77949433737
-
-
Porro A, Chrochemore C, Cambuli F, Iraci N, Contestabile A, Perini G. Nitric oxide control off MYCN expression and multi drug resistance genes in tumours off neural origin. Curr Pharm Design 2010; 16(4): 431-439.
-
Porro A, Chrochemore C, Cambuli F, Iraci N, Contestabile A, Perini G. Nitric oxide control off MYCN expression and multi drug resistance genes in tumours off neural origin. Curr Pharm Design 2010; 16(4): 431-439.
-
-
-
-
18
-
-
77949444253
-
-
Peña-Altamira E, Petazzi P, Contestabile A. Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin. Curr Pharm Design 2010; 16(4): 440-450.
-
Peña-Altamira E, Petazzi P, Contestabile A. Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin. Curr Pharm Design 2010; 16(4): 440-450.
-
-
-
-
19
-
-
77949431180
-
-
Pervin S, Chauduri G, Singh R. NO to breast: when, why and why not? Curr Pharm Design 2010; 16(4): 451-462.
-
Pervin S, Chauduri G, Singh R. NO to breast: when, why and why not? Curr Pharm Design 2010; 16(4): 451-462.
-
-
-
|